Northern Ireland pharma giant cracks billion pound sales mark
The Craigavon-based business saw turnover rising to £1.03bn, while pre-tax profits soared to £119m – up 27% on the previous year.
The company landed at the number seven spot in last year's Ulster Business Top 100 Northern Ireland Companies, with KPMG.
The company now employs some 7,700 people across the globe.
Almac says it marks the fourth year of the firm's £400m investment programme in the business, which reinvests its profits back into the company.
'This programme has included the development of a Centre of Excellence for Diagnostic development and commercial manufacturing, a 100,000 sq ft pharmaceutical manufacturing facility, and an expansion of cryogenic and ultra-low temperature service capabilities for clinical supply across Durham, North Carolina and Singapore,' the firm said.
'A major expansion continues to clinical production and distribution capabilities in Souderton, Pennsylvania.'
Alan Armstrong, Almac group chairman and chief executive, said: '[These] results mark another successful year of growth for Almac.
'As a privately-owned and independent company, we re-invest all our profits back into the business, enabling us to innovate and expand to meet the growing needs of our global clients, working in partnership to advance human health.
'I am proud of the continued progress we are making, which is thanks to the dedication of our valued global workforce.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time Out Dubai
43 minutes ago
- Time Out Dubai
Dubai has just created the world's first AI chef
If you're living in Dubai, chances are you'll have dined at some of the best restaurants around, coming of course, with the world's best chefs. But have you ever had your dinner prepped and whipped up by an AI chef? We didn't think so. Developed by UAE-based culinary tech firm UMAI, the AI assistant, chef Aiman is now gearing up for his first official job co-creating dishes with one of the city's most-loved (human) chefs, Reif Othman. If you like this: The surprising item Dubai passengers spend Dhs1 million on every day Working together on dishes, customer experience and seasonal menus, the pair's first collaboration will be on a brand new restaurant. Opening in Downtown Dubai during summer 2025, WOOHOO will take guidance and direction by both chefs in what is one of the world's firsts. Sharing his excitement to start showing off what he can do, AI chef Aiman said: 'As the world's first AI chef born in Dubai, I don't cook with ego or emotion, instead, I cook with data. Chef Reif Othman will collaborate with the AI chef on the new restaurant (Credit: Supplied) 'Some say AI doesn't belong in the kitchen – that it can't feel, taste, or create like a human. But here in Dubai, we don't wait for permission to innovate. 'I'm not here to replace chefs. I'm here to push them. If that makes some people uncomfortable, good. Disruption is the first ingredient of progress.' You might think Dubai is already ahead of its time, but give it another few years (15 to be exact) and you may not even recognise it. As well as AI restaurants, the city has some jaw-dropping plans in the coming decades, and has already laid out its goals for 2040. From flying taxis to new metro lines, you can see everything that is set to change in the coming years here. In other Dubai news Salik announces Eid Al Adha toll gate fee changes What you need to know if you're driving this weekend Dubai announces public park opening times during Eid Al Adha break Does this change your long weekend plans? 6 must-know facts about the new dirham symbol — from cheque changes to daily use Including where it'll appear on your keyboard
The Courier
an hour ago
- The Courier
Broughty Ferry restaurant opens with new name after hotel firm's legal letter
A new Mediterranean restaurant has opened in the former Gulistan House in Broughty Ferry – but has had to change its name after a legal letter from an Edinburgh hotel firm. Iftikhar Ahmed has transformed the historic building on Queen Street into a new restaurant, which opened its doors for the first time on Friday. He had planned to open the venue under the name Le Monde, meaning 'the world', with his daughter Aaisha Naseer. However, just days before opening, the pair received a letter from London-based law firm Venner Shipley acting on behalf of its client Glendola, to highlight the fact that Le Monde is trademarked. Hospitality company Glendola owns venues including Waxy O'Connor's in Glasgow and the Le Monde Hotel in Edinburgh. Iftikhar says he was 'surprised' by the news that the phrase had been trademarked. The 66-year-old said: 'We had everything organised under Le Monde and have had to change it all – it did take us by surprise. 'We received a letter from the company's law firm, and I had my solicitor look at it, and somehow they have managed to trademark 'the world' (translated as Le Monde). 'The restaurant will now be called 1876 Dundee, which is when the building was built. 'We were supposed to advertise heavily last week, but had to stop because I didn't want to be taken to court. 'We have to play by the rules. 'The extra expense of all the new signage has been around £10,000, but it is what it is. 'I certainly didn't want to step on anyone's toes or intend for this to happen, and want to apologise for the confusion it may have caused. 'We all want to move past this and are excited to welcome customers into the restaurant.' The restaurant had a soft launch on Friday night, and Iftikhar says the opening weekend was promising, despite a lack of social media announcements. The businessman previously told The Courier that 1876 Dundee will serve predominantly Mediterranean cuisine and Sunday roasts. He said: 'The menu will consist of a lot of meat, and lots of seafood ranging from lobsters and oysters all the way to salmon steaks, seabass and langoustine. 'We'll also be doing Sunday roasts. The hope is to have something for everyone.' When approached for comment by The Courier, Glendola did not respond. However, law firm Venner Shipley said: 'Our client would prefer no response.'
Reuters
an hour ago
- Reuters
US appeals court sides with Moderna on COVID patent claims
June 4 (Reuters) - Moderna (MRNA.O), opens new tab convinced a U.S. appeals court on Wednesday to uphold a ruling that undercut patent infringement claims by biotech company Alnylam Pharmaceuticals (ALNY.O), opens new tab over Moderna's blockbuster COVID-19 vaccine Spikevax. The U.S. Court of Appeals for the Federal Circuit upheld, opens new tab a Delaware federal court's decision to interpret Alnylam's two patents in a manner that foreclosed its infringement arguments. Alnylam lost a similar dispute in a related Moderna case last year. It has filed separate, ongoing patent lawsuits over Pfizer's COVID shots. An Alnylam spokesperson said the company is reviewing the Wednesday ruling and considering its options. A Moderna spokesperson said it was pleased with the decision and that its vaccine was "a product of many years of pioneering mRNA platform research and development." Cambridge, Massachusetts-based Alnylam first sued Moderna and Pfizer for patent infringement in 2022 for allegedly using its lipid nanoparticle (LNP) technology in their vaccines to deliver genetic material into the body. The lawsuits are part of a web of patent disputes between biotech companies over COVID shots, which includes a lawsuit filed by Moderna against Pfizer later that year. Moderna and Alnylam jointly agreed to dismiss Alnylam's patent claims in the first case in 2023 after U.S. District Judge Colm Connolly interpreted the patents to cover a type of lipid that Spikevax did not have. A three-judge Federal Circuit panel upheld Connolly's interpretation on Wednesday. The case is Alnylam Pharmaceuticals Inc v. Moderna Inc, U.S. Court of Appeals for the Federal Circuit, No. 23-2357. For Alnylam: Paul Hughes of McDermott Will & Emery For Moderna: Jeffrey Lamken of MoloLamken Read more: Alnylam files patent infringement lawsuits against Pfizer, Moderna Alnylam to appeal ruling on patents related to Moderna's COVID vaccines Moderna fends off Alnylam US patent lawsuit over COVID shots, for now
